1. Home
  2. ETD vs RCKT Comparison

ETD vs RCKT Comparison

Compare ETD & RCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ethan Allen Interiors Inc.

ETD

Ethan Allen Interiors Inc.

HOLD

Current Price

$22.74

Market Cap

569.7M

ML Signal

HOLD

Logo Rocket Pharmaceuticals Inc.

RCKT

Rocket Pharmaceuticals Inc.

HOLD

Current Price

$3.89

Market Cap

534.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ETD
RCKT
Founded
1932
1999
Country
United States
United States
Employees
N/A
202
Industry
Home Furnishings
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
569.7M
534.2M
IPO Year
1996
N/A

Fundamental Metrics

Financial Performance
Metric
ETD
RCKT
Price
$22.74
$3.89
Analyst Decision
Hold
Buy
Analyst Count
1
14
Target Price
$27.00
$29.73
AVG Volume (30 Days)
337.7K
4.3M
Earning Date
04-29-2026
05-07-2026
Dividend Yield
7.97%
N/A
EPS Growth
N/A
N/A
EPS
0.87
N/A
Revenue
$766,784,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$2.73
$64.28
P/E Ratio
$26.09
N/A
Revenue Growth
N/A
N/A
52 Week Low
$21.20
$2.19
52 Week High
$31.41
$8.26

Technical Indicators

Market Signals
Indicator
ETD
RCKT
Relative Strength Index (RSI) 56.34 49.31
Support Level $22.48 $2.95
Resistance Level $25.12 $4.08
Average True Range (ATR) 0.53 0.20
MACD 0.11 0.04
Stochastic Oscillator 83.17 72.19

Price Performance

Historical Comparison
ETD
RCKT

About ETD Ethan Allen Interiors Inc.

Ethan Allen Interiors Inc through its subsidiaries, operates as an interior design company, and a manufacturer and retailer in the home furnishings marketplace. Its product offerings include fabric chairs, beds, wallpapers, desks, and dining tables among others. The company's reportable segments are; Wholesale and Retail. The Wholesale segment is principally involved in the development of the Ethan Allen brand and encompasses all aspects of design, manufacturing, sourcing, marketing, sale, and distribution of home furnishings and accents. The Retail segment which generates maximum revenue, sells home furnishings and accents to clients through company-operated design centers. Geographically, it derives key revenue from the United States and the rest from other regions.

About RCKT Rocket Pharmaceuticals Inc.

Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. It has one reportable segment related to R&D and commercial readiness of its gene therapies.

Share on Social Networks: